ACI: Definition, Uses, and Clinical Overview

ACI Introduction (What it is)

ACI most commonly refers to autologous chondrocyte implantation, a cartilage repair technique.
It uses a person’s own cartilage cells (chondrocytes) to help treat certain cartilage defects.
ACI is most often discussed in knee care, especially in sports medicine and cartilage restoration clinics.
It is typically considered when focal cartilage damage causes pain and limits activity.

Why ACI used (Purpose / benefits)

Healthy knee cartilage forms a smooth, low-friction surface that helps the femur (thigh bone) glide over the tibia (shin bone) and patella (kneecap). When a focal (localized) cartilage defect occurs—often from injury, prior surgery, or wear—patients may experience pain, swelling, catching sensations, and reduced tolerance for walking, stairs, or sport.

ACI is used to address a problem that cartilage has limited ability to heal on its own. The central idea is to introduce cartilage-forming cells back into the damaged area so the defect can fill with repair tissue over time. In appropriate candidates, the intended benefits may include:

• Symptom improvement, such as reduced pain and swelling during activity
• Improved function, including better tolerance for daily tasks and athletics
• Durability for selected defects, particularly larger focal cartilage lesions where simpler techniques may be less suitable
• Joint preservation, aiming to delay progression of symptoms in a knee that is not yet at an arthritis stage requiring joint replacement
• Anatomic restoration, attempting to resurface a discrete area rather than replacing the whole joint

Outcomes vary by clinician and case, and ACI is not used for every type of knee arthritis or cartilage loss pattern.

Indications (When orthopedic clinicians use it)

Orthopedic and sports medicine clinicians may consider ACI in scenarios such as:

• A symptomatic, full-thickness cartilage defect (often described as “grade IV” in some systems) on the femur, trochlea, or patella
• A focal lesion with relatively healthy surrounding cartilage (as opposed to diffuse, “all-over” cartilage thinning)
• Persistent symptoms despite appropriate non-surgical care (varies by clinician and case)
• A cartilage defect associated with a prior injury (for example, a traumatic chondral injury)
• Certain cases after failed prior cartilage procedures (selection depends on defect size, location, and knee alignment)
• Patients who can participate in a structured rehabilitation process and follow-up monitoring (requirements vary by program)

Contraindications / when it’s NOT ideal

ACI is not suitable for every knee problem. Clinicians may look for other approaches when there is:

• Diffuse osteoarthritis (widespread cartilage loss and joint space narrowing), where a focal repair is less likely to match the overall disease pattern
• Active infection or uncontrolled inflammatory joint disease (case-dependent)
• Uncorrected malalignment (for example, significant bow-legged or knock-kneed alignment) that overloads the damaged compartment
• Unaddressed instability, such as significant ligament deficiency (ACL/PCL) that changes joint mechanics
• Significant meniscus deficiency without a plan to address it, since the meniscus helps distribute load
• Poor soft-tissue envelope or scarring that makes surgical access and healing more complex (varies by clinician and case)
• Situations where another cartilage restoration method may be more appropriate for the defect’s size, depth, or bone involvement (choice varies by clinician and case)

How it works (Mechanism / physiology)

ACI is based on a tissue engineering concept: implanting living cartilage cells to help fill a cartilage defect with repair tissue that can better tolerate joint loading than an untreated defect.

Mechanism of action (high level)

1. Cell source (autologous): Chondrocytes are collected from the patient, typically from a less weight-bearing area of the knee.
2. Cell expansion: Those cells are grown in a laboratory to increase the number available for implantation (exact methods vary by manufacturer and facility).
3. Re-implantation into the defect: The expanded cells are placed into the defect and contained so they can remain in the target area. Over time, the goal is maturation of repair tissue and improved joint surface function.

Relevant knee anatomy and tissues

• Articular cartilage: Smooth surface covering the ends of the femur, tibia, and the back of the patella.
• Subchondral bone: Bone under the cartilage; some defects involve bone changes that may influence technique choice.
• Meniscus: Shock-absorbing cartilage pads that help distribute load across the tibiofemoral joint.
• Ligaments (ACL/PCL/MCL/LCL): Stabilizers that affect shear and rotational forces on cartilage.
• Patella and trochlea: The kneecap and its groove; patellofemoral cartilage mechanics differ from the tibiofemoral compartment.

Onset, duration, and reversibility

ACI is not an instant-onset treatment like an anesthetic injection. It is a biologic repair process that evolves over months as tissue matures. Longevity depends on defect characteristics, knee mechanics, rehabilitation participation, and other health factors; results can be durable for some patients, but outcomes vary by clinician and case. Because it involves surgical implantation and tissue remodeling, it is not considered reversible in the way a medication can be stopped; however, future treatments remain possible if symptoms persist.

ACI Procedure overview (How it’s applied)

ACI is a surgical cartilage restoration procedure, often performed in staged steps. Details differ across centers and products, but a typical workflow looks like this:

1. Evaluation and exam
   A clinician reviews symptoms (pain, swelling, catching), prior injuries, and prior procedures. The physical exam focuses on alignment, stability, patellar tracking, tenderness, and effusion (fluid).

2. Imaging and diagnostics
   X-rays help assess alignment and arthritis patterns. MRI commonly evaluates cartilage, bone marrow changes, meniscus, and ligaments. Some cases include diagnostic arthroscopy to confirm defect size and location.

3. Preparation / planning
   The team confirms whether the lesion is focal and suitable, and whether other issues (alignment, ligament stability, meniscus status) need to be addressed at the same time or in a staged manner.

4. Cell harvest (often arthroscopic)
   A small cartilage sample is taken from a lower-load region. The sample is sent for processing and cell expansion (timeline varies by lab and logistics).

5. Implantation (second stage in many protocols)
   The defect is prepared and the cells are placed into it. Depending on the specific technique, cells may be injected under a covering membrane or delivered within a scaffold/matrix (varies by material and manufacturer).

6. Immediate checks
   The surgical team confirms containment and stability of the repair construct and addresses any planned concurrent procedures.

7. Follow-up and rehabilitation
   Rehab protocols are structured and progressive, often including protected weight-bearing and gradual return of motion and strength. Specific timelines vary by clinician and case.

Types / variations

“ACI” is sometimes used as an umbrella term for related autologous chondrocyte techniques. Common variations include:

• First-generation ACI: Chondrocytes implanted under a periosteal flap (tissue layer) harvested from another site. This is discussed historically and may be less common in some regions today.
• Second-generation ACI: Chondrocytes implanted under a collagen membrane rather than periosteum.
• Matrix-assisted ACI (often called MACI): Cells are seeded onto or within a scaffold (matrix) that is secured into the defect. This can simplify cell delivery and containment; specifics vary by product and manufacturer.
• Patellofemoral vs tibiofemoral applications: Location matters because contact pressures, tracking, and defect access differ for the patella/trochlea versus the femoral condyles.
• Isolated cartilage repair vs combined procedures: ACI may be performed alongside procedures that address mechanics, such as osteotomy (alignment correction), ligament reconstruction, or meniscus procedures, when needed (case-dependent).

Pros and cons

Pros:

• Uses the patient’s own cells, which can reduce some compatibility concerns compared with donor tissue
• Targets focal cartilage defects with an intent to restore surface function
• Can be considered for larger lesions where some smaller-defect techniques may be less suitable (selection varies)
• May be combined with procedures that address alignment or stability, supporting overall biomechanics
• Structured rehab and follow-up can provide a clear framework for recovery monitoring
• Preserves the native joint rather than replacing it (when appropriately indicated)

Cons:

• Typically requires more than one step (harvest plus implantation) in many protocols
• Involves surgery and rehabilitation, which can be time-intensive
• Outcomes depend heavily on patient selection and addressing co-existing issues (meniscus, alignment, ligaments)
• Potential for complications such as stiffness, swelling, graft-related issues, or need for additional procedures (risk varies)
• Not designed for diffuse arthritis, where damage is not localized
• Access, availability, and insurance coverage can vary by region and program

Aftercare & longevity

Aftercare for ACI is closely tied to biology: the repair tissue needs time and appropriate mechanical loading to mature. Programs commonly emphasize progressive rehab, but exact protocols vary by clinician and case.

Factors that often influence outcomes and longevity include:

• Defect size, depth, and location (patella vs femoral condyle can behave differently)
• Knee alignment and mechanics: If one compartment is overloaded, repair tissue may be stressed. Some cases require bracing or concurrent/staged alignment procedures (case-dependent).
• Meniscus status: The meniscus helps distribute load; deficiency can increase cartilage stress.
• Ligament stability: Instability can increase shear forces across the repair site.
• Adherence to rehabilitation: Participation in supervised physical therapy and home programming can affect motion, strength, and gait mechanics.
• Weight-bearing status and activity progression: Restrictions and timelines vary; progressing too quickly or too slowly can create different challenges.
• Overall health factors: Body weight, smoking status, metabolic health, and inflammatory conditions can influence healing (impact varies by individual).
• Material and technique choice: Membrane/scaffold properties and fixation methods differ by manufacturer and surgeon preference, which can affect handling and early stability.

Longevity is typically discussed in years rather than weeks, but durability is not guaranteed and varies by clinician and case.

Alternatives / comparisons

ACI is one option within a broader cartilage care spectrum. Clinicians often compare it with:

• Observation and monitoring: For mild symptoms or small lesions, some patients manage with activity modification and follow-up assessments (case-dependent).
• Physical therapy and movement-based care: Strengthening, mobility, and neuromuscular training can reduce symptoms by improving mechanics, even when cartilage damage remains.
• Medications: Anti-inflammatory or pain-modulating medications may help symptoms but do not rebuild cartilage (use depends on medical history and clinician judgment).
• Injections: Corticosteroid, hyaluronic acid, or orthobiologic injections may be considered for symptom control in selected cases; effects, duration, and evidence vary by product and indication.
• Microfracture (marrow stimulation): Creates small holes in bone to stimulate a repair response; often used for smaller defects, with variable durability depending on lesion and patient factors.
• Osteochondral autograft transfer (OATS/mosaicplasty): Transfers plugs of cartilage and bone from one area to another; can be useful for certain small-to-medium defects but is limited by donor site availability.
• Osteochondral allograft transplantation: Uses donor cartilage and bone for larger or bone-involved defects; avoids harvesting from the patient but involves graft availability and matching considerations.
• Arthroplasty (partial or total knee replacement): Considered when arthritis is diffuse and joint surfaces are broadly worn, rather than focal.

The “right” comparison depends on whether the problem is focal cartilage injury versus generalized degenerative arthritis, as well as alignment, stability, and patient goals.

ACI Common questions (FAQ)

Q: Is ACI meant for arthritis or for a specific cartilage defect?
ACI is most commonly used for focal cartilage defects rather than widespread arthritis. When cartilage loss is diffuse across the joint, other strategies may be more appropriate. Candidacy depends on imaging, exam findings, and intraoperative assessment.

Q: Is ACI a one-stage or two-stage process?
Many ACI pathways involve two stages: a harvest procedure and a later implantation after cells are expanded. Some matrix-based approaches still follow a staged model, but logistics vary by program and region. Your clinician’s protocol and the specific product used can influence timing.

Q: How painful is the ACI process?
Pain experiences vary by individual, lesion location, and whether additional procedures are performed. People often report postoperative soreness and swelling that gradually changes during rehabilitation. Pain control strategies and expectations differ by clinician and case.

Q: What kind of anesthesia is used?
ACI surgeries are commonly performed with regional anesthesia, general anesthesia, or a combination, depending on the plan and patient factors. The anesthesia team selects an approach based on overall health, procedure length, and institutional practice. This is decided preoperatively in consultation with the surgical and anesthesia teams.

Q: How long does it take to recover after ACI?
Recovery is usually discussed in phases over months, because cartilage repair tissue matures gradually. Return to higher-impact activities typically takes longer than return to basic daily tasks, and timelines vary by clinician and case. Progress is often guided by symptoms, strength, motion, and functional testing.

Q: Will I be non-weight-bearing after ACI?
Many protocols include a period of protected weight-bearing, especially for certain defect locations. The exact duration depends on the lesion site and size, fixation method, and whether other procedures were done. Your surgical team sets restrictions based on the individual plan.

Q: When can someone drive or return to work?
Driving and work timing depends on which leg was treated, pain control needs, strength, reaction time, and whether work is sedentary or physically demanding. Some people return to desk-based duties earlier than to labor-intensive roles. Clearance criteria vary by clinician and case.

Q: How long do ACI results last?
Durability depends on lesion characteristics, knee mechanics (alignment, meniscus, ligaments), rehabilitation participation, and activity demands. Some patients have long-lasting improvement, while others may have persistent symptoms or need additional treatment. There is no single guaranteed lifespan for the repair.

Q: Is ACI considered safe? What are the risks?
ACI is a commonly performed cartilage restoration option in specialized centers, but it still carries surgical risks. Potential issues can include infection, stiffness, swelling, blood clots, graft-related problems, or need for reoperation; likelihood varies by clinician and case. A clinician typically reviews risks in the context of the specific knee and planned technique.

Q: Why might someone choose ACI instead of microfracture or an osteochondral graft?
Technique selection often depends on defect size, location, and whether bone is involved, plus age, activity goals, and prior procedures. Microfracture is often discussed for smaller lesions, while osteochondral grafts address cartilage with underlying bone. ACI is often considered when a focal cartilage defect is sizable or when prior approaches were not successful, but selection is individualized.